Lei Xu

Merck & Co., Inc., Rahway, NJ, USA (United States) ORCID: 0000-0002-9241-7019

1

h-index

1

Publications

2,300

Citations

Publications

1 shown

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Aurélien Marabelle , Marwan Fakih , Juanita Lopez +18 more

2020 The Lancet Oncology 2300 citations

Frequent Co-Authors

Aurélien Marabelle

Marwan Fakih

Juanita Lopez

Institute of Cancer Research

Manisha H. Shah

The Ohio State University

Ronnie Shapira‐Frommer

Sheba Medical Center

Kazuhiko Nakagawa

Universitair Ziekenhuis Leuven

Researcher Info

h-index: 1
Publications: 1
Citations: 2,300
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9241-7019

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.